Diasorin S.p.a. · MIL:DIA
Diasorin — Investor Day (2011)
9 slides from Diasorin's investor day presentation, 2011
Slide 1: Vitamin D
VITAMIN D Carlo Rosa Chief Executive Officer
Slide 2: Worldwide Vitamin D Market: 2007-2011E
WORLDWIDE VITAMIN D MARKET: 2007-2011E 100.0 56 .3% G R: + CA 1E 90.0 7- 2 01 7% 200 :+ 76 . .1 % 80.0 GR 62 CA G R: + 10 CA -20 1E 70.0 20 07 7- 2 01 8% 200 :+ 78. R Million Tests 60.0 C AG 10 07 -20 50.0 20 40.0 30.0 20.0 10.0 0 2007 00 07 2008 20 008 0008 2009 20 009 0009 2010 20 010 010 2011E 20
Slide 3: Vitamin D Penetration
VITAMIN D PENETRATION 173.5 177.1 200 DS TESTS MKT TESTS 7 17 17 155.6 149.8 147.4 133.5 132.9 125.3 150 113.4 94.9 79.4 100 64.8 TESTS/1000 INHAB 40.5 50 35.1 23.7 23.9 23.6 16.9 16.8 17.0 14.8 14.3 13.1 10.7 6.8 4.6 4.5 1.0 4.1 0.2 0.1 1.2 0 ISRAEL BELGIUM FRANCE CANADA GERMANY ITALY CZECH PORTUGA
Slide 4: Product Cycle of Vitamin D Adoption
PRODUCT CYCLE OF VITAMIN D ADOPTION PRE - MKT PHASE INTRODUCTION GROWTH MATURITY DECLINE USA BELGIUM AUSTRALIAA ISRAEL DENMARK SALES GERMANY FRANCE NETHERLANDS BRAZIL CANADA SPAIN ITALY UK MEXICO CZECH REPUBLIC PORTUGAL JAPAN CHINA* TIME # TESTS / 1% POPULATION PENETRATION *CALCULATED ON 100 MLN POP
Slide 5: Prescriptions and Potential Applications
PRESCRIPTIONS AND POTENTIAL APPLICATIONS INTERNAL MEDICINE HOSPITAL AND HSP LABOUR GPS AND 16% INTERNISTS GENERAL PRACTICE 25% 6% OBSTETRIC & GYNEC. ACCOUNT 4% 4% ENDOCRINOLOGY MULTI SPECIALTY FOR 61% OF 4% 2% PRACTICE NEPHROLOGY TOTAL TESTING 30% 2% 5% 2% REUMATOLOGY PRESCRIPTIONS PEDIATRICS FAMILY
Slide 6: US and Europe Vitamin D Market Penetration
CONSOLIDATED VITAMIN D MARKETS US: VITAMIN D MARKET 21.0% 20.5% 65 MLN TESTS • 40% (125MLN) of the US population is Vitamin D 20.0% MKT PENETRATION% deficient* or insufficient, but less then half is tested 19.5% 19.0% • Vitamin D tests/year can grow from 53MLN (2011E) to 18.5% ~ 65MLN in the next 4
Slide 7: Vitamin D in Emerging Markets
EMERGING VITAMIN D MARKETS CHINA: VITAMIN D MARKET 6% 5 MLN TESTS • Huge potential: unexplored market 5% MKT PENETRATION% • DiaSorin as the only provider on the chinese market 4% with CLIA test just approved 3% 5% • Pricing: increasing 2% 1% 0% 0% 2011E 2015E BRAZIL: VITAMIN D MARKET 7% 12 MLN TESTS
Slide 8: Market Penetration in Japan
VITAMIN D IN JAPAN JAPAN VITAMIN D MARKET In Japan, Calcium and Vitamin D deficiency is more prevalent than in the US and Europe (Calcium and Vitamin D in Osteoporosis, Takuo Fajita, et al. Journal of Bone and Mineral metabolism, Japan Volume 9, N°2, August 1991) Large Japanese Class A evidence Tria
Slide 9: Market Growth Forecast
VITAMIN D MARKET GROWTH FORECAST 160.0 14 .4% R: + C AG 140.0 15E 1E -20 2 01 .0 % 10 R: + 120.0 C AG 15E 1E -20 2 01 100.0 MILLION TESTS 80.0 60.0 40.0 20.0 0 2011E 201 011E 01 1 2015E WW market tests DiaSorin tests DIASORIN AIMS TO MAINTAIN A SIGNIFICANT GROWTH, LEVERAGING ON ITS UNDISPUTED LEADER